FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948827571> ?p ?o ?g. }

• W2948827571 endingPage "1887" @default.
• W2948827571 startingPage "1879" @default.
• W2948827571 abstract "Objective Patients with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) have an elevated risk of cardiovascular disease (CVD). This study was undertaken to develop a clearer understanding of the association between changes in disease activity and lipid levels in AAV, which may inform CVD risk stratification in this population. Methods Lipid levels were assessed in stored serum samples (obtained at baseline and month 6) from the Rituximab for ANCA-Associated Vasculitis (RAVE) trial, which randomized patients to receive either rituximab or cyclophosphamide followed by azathioprine. Paired t-tests and multivariable linear regression were used to assess changes in lipid levels. Results Of the 142 patients with serum samples available, the mean ± SD age was 52.3 ± 14.7 years, 72 (51%) were male, 95 (67%) were proteinase 3 (PR3)–ANCA positive, 72 (51%) had received a new diagnosis of AAV, and 75 (53%) were treated with rituximab. Several lipid levels increased between baseline and month 6, including total cholesterol (+12.4 mg/dl [95% confidence interval (95% CI) +7.1, +21.0]), low-density lipoprotein (+10.3 mg/dl [95% CI +6.1, +17.1]), and apolipoprotein B (+3.5 mg/dl [95% CI +1.0, +8.3]). These changes were observed among newly diagnosed and PR3-ANCA–positive patients but not among those with relapsing disease or myeloperoxidase-ANCA–positive patients. There was no difference in change in lipid levels between rituximab-treated patients and cyclophosphamide-treated patients. Changes in lipid levels correlated with changes in erythrocyte sedimentation rate but not with other inflammatory markers or glucocorticoid exposure. Conclusion Lipid levels increased during remission induction among patients with newly diagnosed AAV and those who were PR3-ANCA positive. Disease activity and ANCA type should be considered when assessing lipid profiles to stratify CVD risk in patients with AAV." @default.
• W2948827571 created "2019-06-14" @default.
• W2948827571 creator A5004355994 @default.
• W2948827571 creator A5012967877 @default.
• W2948827571 creator A5013156684 @default.
• W2948827571 creator A5016851450 @default.
• W2948827571 creator A5018239396 @default.
• W2948827571 creator A5025181406 @default.
• W2948827571 creator A5041400870 @default.
• W2948827571 creator A5042482253 @default.
• W2948827571 creator A5047092553 @default.
• W2948827571 creator A5051953810 @default.
• W2948827571 creator A5073621138 @default.
• W2948827571 creator A5082909035 @default.
• W2948827571 creator A5085370636 @default.
• W2948827571 creator A5087655468 @default.
• W2948827571 date "2019-09-16" @default.
• W2948827571 modified "2023-10-17" @default.
• W2948827571 title "Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis" @default.
• W2948827571 cites W1597643670 @default.
• W2948827571 cites W1923656818 @default.
• W2948827571 cites W1999520120 @default.
• W2948827571 cites W2006765980 @default.
• W2948827571 cites W2024331532 @default.
• W2948827571 cites W2025060860 @default.
• W2948827571 cites W2051466126 @default.
• W2948827571 cites W2063340779 @default.
• W2948827571 cites W2103175993 @default.
• W2948827571 cites W2106077672 @default.
• W2948827571 cites W2110461729 @default.
• W2948827571 cites W2112242969 @default.
• W2948827571 cites W2112677603 @default.
• W2948827571 cites W2115067834 @default.
• W2948827571 cites W2115144341 @default.
• W2948827571 cites W2116332717 @default.
• W2948827571 cites W2117194717 @default.
• W2948827571 cites W2119900188 @default.
• W2948827571 cites W2145169863 @default.
• W2948827571 cites W2163696083 @default.
• W2948827571 cites W2179100316 @default.
• W2948827571 cites W2266467924 @default.
• W2948827571 cites W2317184793 @default.
• W2948827571 cites W2411387333 @default.
• W2948827571 cites W2415614656 @default.
• W2948827571 cites W2474029657 @default.
• W2948827571 cites W2555072770 @default.
• W2948827571 cites W2587817148 @default.
• W2948827571 cites W2745258214 @default.
• W2948827571 cites W2754110304 @default.
• W2948827571 cites W2792539030 @default.
• W2948827571 cites W2802067146 @default.
• W2948827571 cites W2805912431 @default.
• W2948827571 doi "https://doi.org/10.1002/art.41006" @default.
• W2948827571 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6944270" @default.
• W2948827571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31162829" @default.
• W2948827571 hasPublicationYear "2019" @default.
• W2948827571 type Work @default.
• W2948827571 sameAs 2948827571 @default.
• W2948827571 citedByCount "22" @default.
• W2948827571 countsByYear W29488275712019 @default.
• W2948827571 countsByYear W29488275712020 @default.
• W2948827571 countsByYear W29488275712021 @default.
• W2948827571 countsByYear W29488275712022 @default.
• W2948827571 countsByYear W29488275712023 @default.
• W2948827571 crossrefType "journal-article" @default.
• W2948827571 hasAuthorship W2948827571A5004355994 @default.
• W2948827571 hasAuthorship W2948827571A5012967877 @default.
• W2948827571 hasAuthorship W2948827571A5013156684 @default.
• W2948827571 hasAuthorship W2948827571A5016851450 @default.
• W2948827571 hasAuthorship W2948827571A5018239396 @default.
• W2948827571 hasAuthorship W2948827571A5025181406 @default.
• W2948827571 hasAuthorship W2948827571A5041400870 @default.
• W2948827571 hasAuthorship W2948827571A5042482253 @default.
• W2948827571 hasAuthorship W2948827571A5047092553 @default.
• W2948827571 hasAuthorship W2948827571A5051953810 @default.
• W2948827571 hasAuthorship W2948827571A5073621138 @default.
• W2948827571 hasAuthorship W2948827571A5082909035 @default.
• W2948827571 hasAuthorship W2948827571A5085370636 @default.
• W2948827571 hasAuthorship W2948827571A5087655468 @default.
• W2948827571 hasBestOaLocation W29488275712 @default.
• W2948827571 hasConcept C126322002 @default.
• W2948827571 hasConcept C203014093 @default.
• W2948827571 hasConcept C24040308 @default.
• W2948827571 hasConcept C2776015282 @default.
• W2948827571 hasConcept C2776694085 @default.
• W2948827571 hasConcept C2776755627 @default.
• W2948827571 hasConcept C2776760755 @default.
• W2948827571 hasConcept C2778143017 @default.
• W2948827571 hasConcept C2778163477 @default.
• W2948827571 hasConcept C2778270857 @default.
• W2948827571 hasConcept C2778910314 @default.
• W2948827571 hasConcept C2779134260 @default.
• W2948827571 hasConcept C2779338263 @default.
• W2948827571 hasConcept C2780653079 @default.
• W2948827571 hasConcept C2908647359 @default.
• W2948827571 hasConcept C71924100 @default.
• W2948827571 hasConcept C90924648 @default.
• W2948827571 hasConcept C99454951 @default.

• next